Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rossi

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Nature Reviews. Drug Discovery|April 29, 2017
Aptamers as targeted therapeutics: current potential and challengesJiehua Zhou, John Rossi
Nature Reviews. Drug Discovery|November 4, 2016
Aptamers as targeted therapeutics: current potential and challengesJiehua Zhou, John Rossi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 14, 2014
Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapyJiehua Zhou, John Rossi
The American Journal of Bioethics : AJOB|February 7, 2012
Value-ladenness and rationality in health communicationJohn Rossi, Michael Yudell
Journal of Medical Ethics|February 28, 2012
Is there an objective way to compare research risks?John Rossi, Robert M Nelson
Accountability in Research|August 5, 2017
Minimal Risk in Pediatric Research: A Philosophical Review and ReconsiderationJohn Rossi, Robert M Nelson
Kennedy Institute of Ethics Journal|July 30, 2013
Autism spectrum disorders, risk communication, and the problem of inadvertent harmJohn Rossi, Craig Newschaffer, Michael Yudell
Nature Medicine|June 7, 2008
Wandering eye for RNAiJohn Rossi, Phil Zamore, Mark A Kay
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Tissue-Specific Delivery of OligonucleotidesXin Xia, Nicolette Pollock, Jiehua Zhou, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 19, 2003
Treatment of spontaneous and chemically induced EEG paroxysms in the Fischer-344 rat with traditional antiepileptic drugs or AED+CGP 35348 polytherapyGlenn D Ritchie, Mary E Hulme, John Rossi
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Nature Reviews. Drug Discovery|April 29, 2017
Aptamers as targeted therapeutics: current potential and challengesJiehua Zhou, John Rossi
Nature Reviews. Drug Discovery|November 4, 2016
Aptamers as targeted therapeutics: current potential and challengesJiehua Zhou, John Rossi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 14, 2014
Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapyJiehua Zhou, John Rossi
The American Journal of Bioethics : AJOB|February 7, 2012
Value-ladenness and rationality in health communicationJohn Rossi, Michael Yudell
Journal of Medical Ethics|February 28, 2012
Is there an objective way to compare research risks?John Rossi, Robert M Nelson
Accountability in Research|August 5, 2017
Minimal Risk in Pediatric Research: A Philosophical Review and ReconsiderationJohn Rossi, Robert M Nelson
Kennedy Institute of Ethics Journal|July 30, 2013
Autism spectrum disorders, risk communication, and the problem of inadvertent harmJohn Rossi, Craig Newschaffer, Michael Yudell
Nature Medicine|June 7, 2008
Wandering eye for RNAiJohn Rossi, Phil Zamore, Mark A Kay
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Tissue-Specific Delivery of OligonucleotidesXin Xia, Nicolette Pollock, Jiehua Zhou, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 19, 2003
Treatment of spontaneous and chemically induced EEG paroxysms in the Fischer-344 rat with traditional antiepileptic drugs or AED+CGP 35348 polytherapyGlenn D Ritchie, Mary E Hulme, John Rossi
Pageof 9